GRAS Notices
-
GRN No. 851
Pea protein
Intended Use: | For use as a source of protein in foods at levels ranging from 1 to 90 percent in bakery products (e.g., bread, rolls, cakes, pasta), cereals, snack foods (e.g.,chips, crackers, energy bars), ready-to-drink (RTD) beverages, soups, smoothies, fruit juices, protein beverages, dairy and dairy alternatives (e.g., yogurt, ice cream), meal replacements, nutritional bars, clinical nutrition, fruit and vegetable preparation, meat analog products, processed meat, dry blend protein products, extruded products, chocolate and confection compound coatings, non-chocolate confections, and as a binder and extender in meat and poultry applications. Infant formula is excluded from the intended uses. It is also intended for use in specialty foods intended to meet the protein requirements for sports activity or for weight control. Pea protein isolate is also intended to be used as a binder and extender in the following meat and poultry applications: raw comminuted poultry, raw comminuted meat, sausage/hot dogs, and soups/stews/salad/similar products. |
---|---|
Basis: | Scientific procedures |
Notifier: | Roquette Freres |
Notifier Address: | Batiment Alpha 3 Lestrem 62080 FRANCE |
GRAS Notice (releasable information): | GRN 851 with amendments (in PDF) (13.4 MB) |
Date of closure: | Apr 15, 2020 |
FDA's Letter: | FDA has no questions (in PDF) (601 kB) |
-